227 related articles for article (PubMed ID: 9224398)
1. Graft versus host disease in rats made tolerant for organ allografts.
Morrissey NJ; Blom D; Ryan C; Fisher T; Bronsther O; Orloff M
J Surg Res; 1997 May; 69(2):307-15. PubMed ID: 9224398
[TBL] [Abstract][Full Text] [Related]
2. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
[TBL] [Abstract][Full Text] [Related]
3. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
Gorantla VS; Prabhune KA; Perez-Abadia G; Ildstad ST; Maldonado C; Orhun HI; Majzoub RK; Francois CG; Kakoulidis TP; Brouha PC; Anderson GL; Pidwell DJ; Breidenbach WC; Barker JH
Transplantation; 2003 Apr; 75(7):922-32. PubMed ID: 12698075
[TBL] [Abstract][Full Text] [Related]
4. Induction of specific tolerance to small-bowel allografts.
Orloff MS; Fallon MA; DeMara E; Coppage ML; Leong N; Cerilli J
Surgery; 1994 Aug; 116(2):222-8. PubMed ID: 8047988
[TBL] [Abstract][Full Text] [Related]
5. Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells.
Chowdhury NC; Jin MX; Oluwole SF
Transplantation; 1993 Jun; 55(6):1229-35. PubMed ID: 8516807
[TBL] [Abstract][Full Text] [Related]
6. Lymphadenectomy prior to rat hind limb allotransplantation prevents graft-versus-host disease in chimeric hosts.
Brouha PC; Perez-Abadia G; Francois CG; Laurentin-Perez LA; Gorantla V; Vossen M; Tai C; Pidwell D; Anderson GL; Stadelmann WK; Hewitt CW; Kon M; Barker JH; Maldonado C
Transpl Int; 2004 Aug; 17(7):341-50. PubMed ID: 15349719
[TBL] [Abstract][Full Text] [Related]
7. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
9. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease.
Hess RA; Tschudy DP; Blaese RM
J Immunol; 1987 Nov; 139(9):2845-9. PubMed ID: 2889780
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of chimerism in the rat tolerant to a renal allograft.
Naar JD; Fisher RA; Saggi BH; Wakely PE; Tawes JW; Posner MP
J Surg Res; 1998 Jul; 77(2):179-86. PubMed ID: 9733606
[TBL] [Abstract][Full Text] [Related]
13. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
14. UV-B modulation of haplo-identical bone marrow cells in the prevention of GVHD and induction of specific transplantation tolerance to intestinal allografts.
Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
Transpl Immunol; 1994 Dec; 2(4):331-6. PubMed ID: 7704543
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of graft-host-tolerance in murine radiation chimeras transplanted across minor histocompatibility barriers.
Perreault C; Bélanger R; Gyger M; Allard A; Brochu S
Bone Marrow Transplant; 1989 Jan; 4(1):83-7. PubMed ID: 2647191
[TBL] [Abstract][Full Text] [Related]
16. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
Song J; Ito T; Matsuda C; Tanemura M; Nishida T; Nozawa M; Sawa Y
Transplant Proc; 2006 Dec; 38(10):3181-3. PubMed ID: 17175216
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of UVB prevention of graft versus host disease.
Greenfeld JI; Chabot JA; Oluwole SF; Hardy MA
J Surg Res; 1996 Jan; 60(1):137-41. PubMed ID: 8592404
[TBL] [Abstract][Full Text] [Related]
18. Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.
Vizler C; Jánossy T; Baranyi L; Végh P
Cell Immunol; 1993 Feb; 146(2):431-7. PubMed ID: 8174181
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
20. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
